Methionine 274 Is Not the Determining Factor for Selective Inhibition of Histone Deacetylase 8 (HDAC8) by L-Shaped

Niklas Jänsch1, Kim Leoni Lang1, Franz-Josef Meyer-Almes1

  • 1Department of Chemical Engineering and Biotechnology, University of Applied Sciences Darmstadt, Haardtring 100, 64295 Darmstadt, Germany.

Insights

Methionine 274 in Histone Deacetylase 8 (HDAC8) does not solely control the binding pocket for L-shaped inhibitors. While M274 exchange impacts enzyme activity, it is not the key factor for selective inhibitor recognition.

Area of Science:

  • Biochemistry
  • Enzyme kinetics
  • Structural biology

Background:

  • Histone Deacetylase 8 (HDAC8) is a therapeutic target for neuroblastoma.
  • L-shaped inhibitors selectively target HDAC8.
  • A theoretical study proposed Methionine 274 (M274) acts as a switch for a transient binding pocket induced by L-shaped inhibitors.

Purpose of the Study:

  • To experimentally validate the role of M274 in HDAC8 inhibition by L-shaped compounds.
  • To investigate the impact of M274 exchange on HDAC8 thermostability, functionality, and inhibitor binding kinetics.

Main Methods:

  • Site-directed mutagenesis to create M274 variants of HDAC8.
  • Biophysical techniques (thermostability assays, enzyme activity assays) to characterize enzyme variants.
  • Binding kinetics analysis using L-shaped and linear inhibitors.

Main Results:

  • Exchange of M274 significantly affected HDAC8 enzyme activity.
  • M274 was not the sole determinant for selective binding of L-shaped inhibitors to HDAC8.
  • Binding kinetics revealed insights into inhibitor-enzyme interactions.

Conclusions:

  • The role of M274 in HDAC8 inhibition is complex and not limited to controlling the binding pocket for L-shaped inhibitors.
  • Further studies are needed to fully elucidate the mechanism of selective HDAC8 inhibition.

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.6K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
8.4K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K